Vincamine

Vincamine

SCHEMBL8970683

CC[C@@]12CCCN3CCc4c(n(c5ccccc45)[C@@](O)(C(=O)OC)C1)[C@H]32

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 1.00
KCNH2 Q12809 3/20 1.00
CYP2D6 P10635 3/20 1.00
HIF1A Q16665 3/20 1.00
MEN1 O00255 3/20 1.00
KMT2A Q03164 3/20 1.00
KDM4E B2RXH2 2/20 1.00
MAPT P10636 2/20 1.00
GAA P10253 1/20 1.00
CASP6 P55212 1/20 1.00
L3MBTL1 Q9Y468 1/20 1.00
NR1I2 O75469 3/20 0.78
PDE4D Q08499 2/20 0.78
HRH3 Q9Y5N1 2/20 0.78
OPRK1 P41145 1/20 0.78
LMNA P02545 3/20 0.57
CYP1A2 P05177 2/20 0.57
TSHR P16473 2/20 0.57
CYP2C9 P11712 1/20 0.57
CYP2C19 P33261 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Vincamine SCHEMBL14095103 1.00 CYP3A4 (1.00) CYP3A4KCNH2CYP2D6HIF1AMEN1
Vincamine SCHEMBL147179 1.00 CYP3A4 (1.00) CYP3A4KCNH2CYP2D6HIF1AMEN1
Vincamine SCHEMBL3767 1.00 CYP3A4 (1.00) CYP3A4KCNH2CYP2D6HIF1AMEN1
Vincamine SCHEMBL30892136 1.00 CYP3A4 (1.00) CYP3A4KCNH2CYP2D6HIF1AMEN1
Vincamine SCHEMBL29710919 1.00 CYP3A4 (1.00) CYP3A4KCNH2CYP2D6HIF1AMEN1
Vincamine SCHEMBL8134417 0.99 CYP3A4 (0.98) CYP3A4KCNH2CYP2D6HIF1AMEN1
Vincamine SCHEMBL6631357 0.98 CYP3A4 (0.96) CYP3A4KCNH2CYP2D6HIF1AMEN1
Vincamine SCHEMBL5712113 0.98 CYP3A4 (0.96) CYP3A4KCNH2CYP2D6HIF1AMEN1
Vincamine SCHEMBL6162410 0.97 CYP3A4 (0.95) CYP3A4KCNH2CYP2D6HIF1AMEN1
Vincamine SCHEMBL11619815 0.97 CYP3A4 (0.93) CYP3A4KCNH2CYP2D6HIF1AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5589486-A ANTIHYPOXIC OR ANTIISCHEMIC AGENTS RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 1996-12-31 US disclosed
EP-0490560-B1 1,2,3,6-Tetrahydropyridine derivatives RICHTER GEDEON VEGYESZET (HU) 1996-03-20 EP disclosed
EP-0642497-A1 NOVEL N-HYDROXYALKYL-SUBSTITUTED 1,2,3,6-TETRAHYDROPYRIDINE AND PIPERIDINE DERIVATIVES RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) 1995-03-15 EP disclosed
US-5225416-A 1,2,3,6-TETRAHYDROPYRIDINE DERIVATIVES USEFUL FOR IMPROVING CEREBRAL BLOOD CIRCULATION RICHTER GEDEON VEGYESZETI TERMEKEK GYARA RT. (HU) 1993-07-06 US disclosed
WO-1993011107-A1 NOVEL N-HYDROXYALKYL-SUBSTITUTED 1,2,3,6-TETRAHYDROPYRIDINE AND PIPERIDINE DERIVATIVES Richter Gedeon Vegyészeti Gyár Rt. (HU) 1993-06-10 WO disclosed
US-5204355-A Reducing or inhibitory effect on cerebral edema, antihypoxic agent RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 1993-04-20 US disclosed
EP-0491549-A1 Novel 15-nitro-2beta, 3beta-dihydro- and 15-nitro-2beta,3beta,6,7-tetrahydrotabersonine derivatives, pharmaceutical compositions containing them and process for preparing same RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 1992-06-24 EP disclosed
EP-0490560-A1 1,2,3,6-Tetrahydropyridine derivatives RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) 1992-06-17 EP disclosed